Brandes Investment Partners LP Has Raised Its Infosys LTD (INFY) Position; Accelerate Diagnostics (AXDX) Shareholder Miura Global Management Has Decreased Its Position by $17.16 Million

April 19, 2018 - By Clifton Ray

Infosys Limited (NYSE:INFY) Logo

Brandes Investment Partners Lp increased its stake in Infosys Ltd (INFY) by 150.65% based on its latest 2017Q4 regulatory filing with the SEC. Brandes Investment Partners Lp bought 790,457 shares as the company’s stock rose 10.06% while stock markets declined. The institutional investor held 1.32M shares of the edp services company at the end of 2017Q4, valued at $21.33 million, up from 524,690 at the end of the previous reported quarter. Brandes Investment Partners Lp who had been investing in Infosys Ltd for a number of months, seems to be bullish on the $39.84B market cap company. The stock increased 0.59% or $0.1 during the last trading session, reaching $16.93. About 12.31 million shares traded or 98.04% up from the average. Infosys Limited (NYSE:INFY) has risen 12.51% since April 19, 2017 and is uptrending. It has outperformed by 0.96% the S&P500.

Pasco Alfaro / Richard Tumure decreased its stake in Accelerate Diagnostics Inc (AXDX) by 68.75% based on its latest 2017Q4 regulatory filing with the SEC. Miura Global Management Llc sold 660,000 shares as the company’s stock declined 17.34% with the market. The hedge fund run by Pasco Alfaro / Richard Tumure held 300,000 shares of the capital goods company at the end of 2017Q4, valued at $7.86M, down from 960,000 at the end of the previous reported quarter. Miura Global Management Llc who had been investing in Accelerate Diagnostics Inc for a number of months, seems to be less bullish one the $1.39 billion market cap company. The stock increased 1.01% or $0.25 during the last trading session, reaching $24.95. About 193,940 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since April 19, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Among 22 analysts covering Infosys (NYSE:INFY), 5 have Buy rating, 3 Sell and 14 Hold. Therefore 23% are positive. Infosys had 44 analyst reports since July 24, 2015 according to SRatingsIntel. As per Thursday, November 16, the company rating was maintained by KeyBanc Capital Markets. The stock of Infosys Limited (NYSE:INFY) has “Neutral” rating given on Monday, August 21 by JP Morgan. The stock of Infosys Limited (NYSE:INFY) earned “Hold” rating by Cowen & Co on Monday, January 15. The rating was maintained by Robert W. Baird with “Hold” on Friday, November 10. Cowen & Co maintained Infosys Limited (NYSE:INFY) rating on Thursday, October 12. Cowen & Co has “Hold” rating and $15.0 target. Susquehanna maintained Infosys Limited (NYSE:INFY) rating on Tuesday, September 1. Susquehanna has “Neutral” rating and $19 target. The rating was upgraded by Goldman Sachs on Thursday, May 26 to “Buy”. The stock of Infosys Limited (NYSE:INFY) has “Buy” rating given on Monday, April 16 by Jefferies. The rating was downgraded by Susquehanna to “Negative” on Monday, February 5. The rating was maintained by Robert W. Baird on Tuesday, October 3 with “Hold”.

Brandes Investment Partners Lp, which manages about $26.91B and $4.95 billion US Long portfolio, decreased its stake in Chesapeake Energy Corp (NYSE:CHK) by 2.12M shares to 2.95 million shares, valued at $11.67 million in 2017Q4, according to the filing. It also reduced its holding in China Yuchai Intl Ltd (NYSE:CYD) by 235,947 shares in the quarter, leaving it with 948,550 shares, and cut its stake in Petroleo Brasileiro Sa Petro.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on May, 4. They expect $-0.31 EPS, down 14.81% or $0.04 from last year’s $-0.27 per share. After $-0.27 actual EPS reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 14.81% negative EPS growth.

Miura Global Management Llc, which manages about $2.90B and $344.33M US Long portfolio, upped its stake in Asml Holding N V (NASDAQ:ASML) by 20,000 shares to 120,000 shares, valued at $20.86M in 2017Q4, according to the filing.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.82, from 1.63 in 2017Q3. It is negative, as 21 investors sold AXDX shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. Fairfield Bush &, a Connecticut-based fund reported 10,840 shares. Citigroup has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Ubs Asset Mngmt Americas invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). 631,586 were accumulated by Loomis Sayles & Co Lp. Price T Rowe Assoc Md invested in 0% or 9,113 shares. Swiss Financial Bank invested in 55,900 shares or 0% of the stock. Arrowmark Colorado Holding Limited Liability Com stated it has 0.25% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Principal Grp Inc Inc holds 0% or 8,294 shares. Moreover, Atlantic Trust Grp has 0.01% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 46,660 shares. State Board Of Administration Of Florida Retirement System has 16,068 shares for 0% of their portfolio. State Street stated it has 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Plante Moran Financial Advsr Limited Liability Corp holds 0.06% or 4,000 shares in its portfolio. Trellus Mngmt Co Ltd Co accumulated 8,678 shares. The Illinois-based Balyasny Asset Ltd Liability Company has invested 0.03% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Oz Mngmt LP holds 0.01% or 53,100 shares.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. William Blair initiated Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Friday, January 8 with “Outperform” rating. On Wednesday, July 12 the stock rating was reinitiated by BTIG Research with “Buy”. JP Morgan initiated Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Thursday, March 24 with “Overweight” rating. The firm earned “Neutral” rating on Tuesday, August 25 by BTIG Research. The firm earned “Buy” rating on Sunday, September 17 by Piper Jaffray. As per Wednesday, December 16, the company rating was initiated by Piper Jaffray. On Thursday, August 3 the stock rating was maintained by Piper Jaffray with “Buy”. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Neutral” rating by BTIG Research on Wednesday, December 13. The rating was maintained by JP Morgan on Tuesday, August 9 with “Overweight”.

Infosys Limited (NYSE:INFY) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>